Cargando…
Discrepancies between tumor genomic profiling and germline genetic testing
BACKGROUND: Tumor genomic profiling (TGP) often incidentally identifies germline pathogenic variants (PVs) associated with cancer predisposition syndromes. Methods used by somatic testing laboratories, including germline analysis, differ from designated germline laboratories that have optimized the...
Autores principales: | Pauley, K., Koptiuch, C., Greenberg, S., Kohlmann, W., Jeter, J., Colonna, S., Werner, T., Kinsey, C., Gilcrease, G., Weis, J., Whisenant, J., Florou, V., Garrido-Laguna, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511791/ https://www.ncbi.nlm.nih.gov/pubmed/35780590 http://dx.doi.org/10.1016/j.esmoop.2022.100526 |
Ejemplares similares
-
Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants
por: Pauley, Kristen, et al.
Publicado: (2022) -
Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumab
por: Nevala-Plagemann, Christopher, et al.
Publicado: (2019) -
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake
por: Ramsey, Mitchell L., et al.
Publicado: (2022) -
Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction
por: Florou, Vaia, et al.
Publicado: (2021) -
Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world study
por: Miotke, Laura, et al.
Publicado: (2022)